Krystal Biotech, Inc. (KRYS)
260.33
-4.67
(-1.76%)
USD |
NASDAQ |
Mar 05, 16:00
258.99
-1.34
(-0.51%)
Pre-Market: 20:00
Krystal Biotech Cash from Investing (TTM) : -58.42M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Amicus Therapeutics, Inc. | -46.43M |
| DexCom, Inc. | 536.00M |
| Scholar Rock Holding Corp. | 218.69M |
| Alkermes Plc | 295.50M |
| Stoke Therapeutics, Inc. | -124.93M |